dpp 4 inhibitors vs glp 1 agonist DPP-4 and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research Dipeptidyl peptidase-4 inhibitor - Wikipedia
Description
& Wu, G
doi: 10.2337/db17-1212
Acting as incretin mimetics, they enhance glucose-dependent insulin secretion, suppress glucagon release, delay gastric emptying, and promote satiety, addressing several core abnormalities in T2DM pathophysiology (Ahmann et al., 2015)
10,11 REFERENCES 1
With this meal, gastroparesis is defined as an intragastric retention of more than 60% of the solid meal at two hours or more than 10% at four hours
